Relapsed/Refractory CLL/SLL and MCL: Training and Resources to Optimize Outcomes

Download slides, watch a webcast, and read a commentary featuring expert perspectives on advances in BTK inhibitor treatment for relapsed/refractory CLL and MCL.

Share

Program Content

Activities

Call to Action: R/R CLL and MCL
Call to Action: Addressing Barriers to Optimal Management of Patients With Relapsed/Refractory CLL and MCL Using Innovative Therapies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 13, 2023

Expires: September 12, 2024

Activities

Treating R/R CLL/SLL and MCL
Optimizing Outcomes for Relapsed/Refractory CLL/SLL and MCL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2023

Expires: October 29, 2024

Activities

Optimizing Outcomes in R/R Blood Cancers
Relapsed/Refractory CLL/SLL and MCL: Training and Resources to Optimize Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2023

Expires: December 13, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported by an educational grant from Lilly.

Lilly